A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2700-2707

  Boparai, Karam S ^a   Dekker, Evelien ^a   Polak, Mirjam M ^a   Musler, Alex R ^a   Van Eeden, Susanne ^a   Van Noesel, Carel J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; B RAF KINASE; PROTEIN MLH1; WNT PROTEIN;

ADENOMA; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASTIC POLYPOSIS SYNDROME; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; POLYP; POLYPOSIS; PRIORITY JOURNAL; PROTEIN METHYLATION;

EID: 79959409983     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.023     Document Type: Article

References (53)

1. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK: Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008, 100:1672-1694
2. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532
4. Hawkins NJ, Ward RL: Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001, 93:1307-1313 (Pubitemid 32910571)
5. Iino H, Jass JR, Simms LA, Young J, Leggett B, Ajioka Y, Watanabe H: DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 1999, 52:5-9 (Pubitemid 29023500)
6. Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, Meltzer SJ, Wright C, Searle J, Young J, Leggett BA: Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999, 52:455-460 (Pubitemid 29281765)
7. Jass JR, Iino H, Ruszkiewicz A, Painter D, Solomon MJ, Koorey DJ, Cohn D, Furlong KL, Walsh MD, Palazzo J, Edmonston TB, Fishel R, Young J, Leggett BA: Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 2000, 47:43-49 (Pubitemid 30430410)
8. Jass JR, Young J, Leggett BA: Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 2000, 37:295-301
9. Jass JR: Serrated route to colorectal cancer: back street or super highway? J Pathol 2001, 193:283-285 (Pubitemid 32229857)
10. Makinen MJ, George SM, Jernvall P, Makela J, Vihko P, Karttunen TJ: Colorectal carcinoma associated with serrated adenoma: prevalence, histological features, and prognosis. J Pathol 2001, 193:286-294 (Pubitemid 32229858)
11. Yao T, Nishiyama K, Oya M, Kouzuki T, Kajiwara M, Tsuneyoshi M: Multiple "serrated adenocarcinomas" of the colon with a cell lineage common to metaplastic polyp and serrated adenoma: case report of a new subtype of colonic adenocarcinoma with gastric differentiation J Pathol 2000, 190:444-449 (Pubitemid 30163584)
12. Jass JR: Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2005, 2:398-405 (Pubitemid 43115008)
13. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004, 53:1137-1144 (Pubitemid 38961968)
14. McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA, Young J, Jass JR: Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 2004, 3:101-107 (Pubitemid 40645891)
15. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE: Tumorigenesis: rAF/RAS oncogenes and mismatchrepair status. Nature 2002, 418:934 (Pubitemid 34976022)
16. Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA, Borten MM, Stitz R, Searle J, McKeone D, Fraser L, Purdie DR, Podger K, Price R, Buttenshaw R, Walsh MD, Barker M, Leggett BA, Jass JR: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001, 159:2107-2116 (Pubitemid 33104265)
17. Azimuddin K, Stasik JJ, Khubchandani IT, Rosen L, Riether RD, Scarlatto M: Hyperplastic polyps: "more than meets the eye"? Report of sixteen cases. Dis Colon Rectum 2000, 43:1309-1313
18. Warner AS, Glick ME, Fogt F: Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. Am J Gastroenterol 1994, 89:123-125 (Pubitemid 24020067)
19. Urbanski SJ, Kossakowska AE, Marcon N, Bruce WR: Mixed hyperplastic adenomatous polyps: an underdiagnosed entity: report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp Am J Surg Pathol 1984, 8:551-556 (Pubitemid 14083982)
20. Goldstein NS, Bhanot P, Odish E, Hunter S: Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003, 119:778-796 (Pubitemid 37047838)
21. Boparai KS, Dekker E, van ES, Polak MM, Bartelsman JF, Mathus-Vliegen EM, Keller JJ, van Noesel CJ: Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008, 135:2014-2018
22. Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, Cowie S, Nasioulas S, du SD, Young J, Leggett B, Jass J, Macrae F: Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006, 131:30-39 (Pubitemid 44015745)
23. Carvajal-Carmona L, Howarth K, Lockett M, Polanco-Echeverry G, Volikos E, Gorman M, Barclay E, Martin L, Jones A, Saunders B, Guenther T, Donaldson A, Paterson J, Frayling I, Novelli M, Phillips R, Thomas H, Silver A, Atkin W, Tomlinson I: Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol 2007, 212:378-385 (Pubitemid 47099014)
24. Hyman NH, Anderson P, Blasyk H: Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004, 47:2101-2104 (Pubitemid 40179073)
25. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR: Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000, 119:323-332 (Pubitemid 30621982)
26. Rubio CA, Stemme S, Jaramillo E, Lindblom A: Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006, 38: 266-270
27. Oono Y, Fu K, Nakamura H, Iriguchi Y, Yamamura A, Tomino Y, Oda J, Mizutani M, Takayanagi S, Kishi D, Shinohara T, Yamada K, Matumoto J, Imamura K: Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009, 54:906-909
28. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, Nagengast FM, van LM, van Noesel CJ, Houben M, Cats A, van Hest LP, Fockens P, Dekker E: Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010, 59:1094-1100
29. Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, Gattas M, Walsh MD, Clendenning M, McKeone D, Walters R, Roberts A, Young A, Hampel H, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Chow E, Parry S, Woodall S, Tucker K, Muir A, Field M, Greening S, Gallinger S, Green J, Woods MO, Spaetgens R, de la Chapelle A, Macrae F, Walker NI, Jass JR, Young JP: Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis 2010, 25:703-712
30. Burt RW, Jass J. Hyperplastic polyposis. World Health Organisation Classification of Tumours: Pathology and Genetics. Edited by SR Hamilton, LA Aaltonen. Berlin, Springer-Verlag, 2000, pp 135-136
31. Khalid O, Radaideh S, Cummings OW, O'Brien MJ, Goldblum JR, Rex DK: Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009, 15:3767-3770
32. Sandmeier D, Seelentag W, Bouzourene H: Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch 2007, 450:613-618 (Pubitemid 46986228)
33. Sandmeier D, Benhattar J, Martin P, Bouzourene H: Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps. Histopathology 2009, 55:206-213
34. Wong NA, Hunt LP, Novelli MR, Shepherd NA, Warren BF: Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 2009, 55:63-66
35. Hamilton SR, Vogelstein B, Kudo S, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon, France, IARC Press, 2000, pp 104-119
36. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D, Young J: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology 2006, 49:121-131 (Pubitemid 44079695)
37. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP: Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005, 124:380-391 (Pubitemid 41232924)
38. de Leng WW, Keller JJ, Luiten S, Musler AR, Jansen M, Baas AF, de Rooij FW, Gille JJ, Menko FH, Offerhaus GJ, Weterman MA: STRAD in Peutz-Jeghers syndrome and sporadic cancers. J Clin Pathol 2005, 58:1091-1095 (Pubitemid 41416061)
39. de Leng WW, Westerman AM, Weterman MA, de Rooij FW, Dekken HH, De Goeij AF, Gruber SB, Wilson JH, Offerhaus GJ, Giardiello FM, Keller JJ: Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas. Clin Cancer Res 2003, 9:3065-3072 (Pubitemid 36993269)
40. Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, Rashid A: BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 2005, 166:1069-1075 (Pubitemid 40524431)
41. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A: Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 2002, 160:529-536 (Pubitemid 34160330)
42. Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, Rashid A: BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 2005, 166:1069-1075 (Pubitemid 40524431)
43. Chan TL, Zhao W, Leung SY, Yuen ST: BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003, 63:4878-4881 (Pubitemid 37022620)
44. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass JR: Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006, 55:1467-1474 (Pubitemid 44476793)
45. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, Wolff RK, Slattery ML: Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 2005, 65:6063-6069
46. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, Roignot P, Rat P, Bouvier AM, Laurent-Puig P, Faivre J, Chapusot C, Piard F: Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 2008, 68:8541-8546
47. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS: CpG island methylator phenotype, microsatellite instability: BRAF mutation and clinical outcome in colon cancer. Gut 2009, 58:90-96
48. de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bruine AP, van Engeland M: MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol 2009, 20:1216-1222
49. Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S: A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009, 137:1609-1620
50. Makinen JM, Makinen MJ, Karttunen TJ: Serrated adenocarcinoma of the rectum associated with perianal Paget's disease: a case report. Histopathology 2002, 41:177-179 (Pubitemid 34985197)
51. Makinen MJ: Colorectal serrated adenocarcinoma. Histopathology 2007, 50:131-150 (Pubitemid 44953404)
52. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532
53. Thorstensen L, Lind GE, Lovig T, Diep CB, Meling GI, Rognum TO, Lothe RA: Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 2005, 7:99-108 (Pubitemid 40315987)